SPECIAL PHARMACOLOGY AND DRUG BIOTECHNOLOGY
Course objectives
General objectives The basic objective of the course is to enable the graduate in Pharmaceutical Biotechnology to achieve a high qualification in the field of pharmacology, which is essential for his or her entry into the world of work, in the fields of design and development of innovative biopharmaceuticals and the study of their cellular and molecular mechanisms. Specific objectives The lectures will aim to provide basic pharmacological knowledge on the main classes of drugs used in clinical therapy, including biotechnological drugs and innovative therapies already available. Particular attention will be given to the cellular and molecular mechanisms by which they produce therapeutic effects and the rationale behind the development of new drugs, where current therapies are not yet optimal, particularly in terms of efficacy or safety. Particular attention will be given to recent scientific literature concerning the identification of new therapeutic targets and the design of innovative biotechnological drugs. The course will also provide basic knowledge on in vitro and in vivo experimental models most commonly used for the development of new drugs, as well as on approaches that allow the analysis and evaluation of experimental results. The course aims, in fact, to train future pharmaceutical biotechnologists able to face, with critical skills and judgment, the problems related to the screening of new drugs, especially biotechnological and/ or biological drugs, in relation to existing drugs. Among the skills that will be acquired by the student at the end of the course there is also the ability to communicate what has been learned, which will be continuously stimulated through a timely and constant interaction with the teacher in the classroom, during the course. In particular, the student will be called to participate actively in the lesson through various modes of interaction with the teacher or colleagues, with the aim of recalling or linking what was discussed in the lesson to topics already covered, in this course or in the other courses of the cycle. Finally, through reference to scientific databases (e.g. Pubmed) or websites of public or private organizations in the field (e.g. AIFA, ISS, Società Italiana di Farmacologia), the course will train the student to use these useful sources in order to continue the continuous updating independently during his professional career. Expected learning outcomes At the end of the course, the student will have acquired in-depth knowledge about the biotechnological drugs already in use and will be able to apply them for the identification of new targets and the consequent design and study of innovative drugs. The student will also have acquired the skills to evaluate not only the design of a preclinical study but also that of a clinical trial for the development of innovative drugs and/ or biotechnology, with particular attention to the analysis of primary and secondary endpoints.
Program - Frequency - Exams
Course program
Prerequisites
- Lesson code10620632
- Academic year2025/2026
- CoursePharmaceutical Biotechnology
- CurriculumSingle curriculum
- Year1st year
- Semester2nd semester
- SSDBIO/14
- CFU6
- Subject areaDiscipline farmaceutiche